These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2496426)

  • 1. Potentiation of oxotremorine-induced hypothermia by alaproclate in PCA lesioned and non-lesioned rats.
    Dilsaver SC; Normile HJ; Altman HJ
    Psychopharmacology (Berl); 1989; 97(1):51-3. PubMed ID: 2496426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and in vitro studies on the potentiation of muscarinic receptor stimulation by alaproclate, a selective 5-HT uptake blocker.
    Ogren SO; Nordström O; Danielsson E; Peterson LL; Bartfai T
    J Neural Transm; 1985; 61(1-2):1-20. PubMed ID: 2984330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonergic potentiation of muscarinic agonist evoked tremor and salivation in rat and mouse.
    Ogren SO; Carlsson S; Bartfai T
    Psychopharmacology (Berl); 1985; 86(3):258-64. PubMed ID: 3929296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a possible functional interaction between serotonergic and cholinergic mechanisms in memory retrieval.
    Altman HJ; Stone WS; Ogren SO
    Behav Neural Biol; 1987 Jul; 48(1):49-62. PubMed ID: 3632552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation into the effects in-vitro of the 5-hydroxytryptamine reuptake inhibitor, alaproclate, on carbachol-stimulated inositol phospholipid breakdown in the rat cerebral cortex.
    Fowler CJ; Thorell G; Ogren SO
    J Pharm Pharmacol; 1987 Dec; 39(12):1015-8. PubMed ID: 2894427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GEA 857, a putative blocker of potassium conductance, enhances muscarinic agonist-evoked responses: dissociation from an action on 5-HT mechanisms.
    Ogren SO; Bartfai T; Hedlund B; Lindberg UH
    Pharmacol Toxicol; 1992 Aug; 71(2):112-9. PubMed ID: 1438027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alaproclate: further pharmacological evidence for 5-HT uptake inhibition in vivo.
    Rawłów A; Pawłowski L; Przegaliński E
    Arch Int Pharmacodyn Ther; 1983 Oct; 265(2):219-29. PubMed ID: 6651410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of calcium channel inhibitors on the hypothermic response to oxotremorine in normo and hypercholinergic rats.
    Pucilowski O; Overstreet DH; Rezvani AH; Janowsky DS
    J Pharm Pharmacol; 1991 Jun; 43(6):436-9. PubMed ID: 1681059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in behavioral responses to a cholinergic agonist in post-pubertal rats with neonatal ventral hippocampal lesions: relationship to changes in muscarinic receptor levels.
    Laplante F; Nakagawasai O; Srivastava LK; Quirion R
    Neuropsychopharmacology; 2005 Jun; 30(6):1076-87. PubMed ID: 15637638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-reversal of scopolamine- or age-related EEG changes by ondansetron, methysergide or alaproclate.
    Riekkinen P; Sirviö J; Riekkinen P
    Psychopharmacology (Berl); 1991; 103(4):567-70. PubMed ID: 1829538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The characterization of oxotremorine-induced hypothermic response in the rat.
    Ryan PM; Kelly JP; Chambers PL; Leonard BE
    Pharmacol Toxicol; 1996 Nov; 79(5):238-40. PubMed ID: 8936556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential response to cholinergic stimulation in psychogenitically selected rat lines.
    Martin JR; Driscoll P; Gentsch C
    Psychopharmacology (Berl); 1984; 83(3):262-7. PubMed ID: 6433388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of increased serotonergic and decreased cholinergic activities on spatial navigation performance in rats.
    Riekkinen P; Jäkälä P; Sirviö J; Riekkinen P
    Pharmacol Biochem Behav; 1991 May; 39(1):25-9. PubMed ID: 1924509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alaproclate, a new selective 5-HT uptake inhibitor with therapeutic potential in depression and senile dementia.
    Ogren SO; Holm AC; Hall H; Lindberg UH
    J Neural Transm; 1984; 59(4):265-88. PubMed ID: 6205120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of manipulation of presynaptic 5-HT nerve terminals on postsynaptic 5-HT1 and 5-HT2 binding sites of the rat brain.
    Hall H; Wedel I
    J Neural Transm; 1985; 64(2):129-43. PubMed ID: 4078567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinergic/serotonergic interactions in hypothermia: implications for rat models of depression.
    Overstreet DH; Daws LC; Schiller GD; Orbach J; Janowsky DS
    Pharmacol Biochem Behav; 1998 Apr; 59(4):777-85. PubMed ID: 9586831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective breeding for increased cholinergic function: increased serotonergic sensitivity.
    Wallis E; Overstreet DH; Crocker AD
    Pharmacol Biochem Behav; 1988 Oct; 31(2):345-50. PubMed ID: 3244712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic treatment with ethanol produces supersensitivity to oxotremorine.
    Majchrzak MJ; Dilsaver SC
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(3):379-86. PubMed ID: 2359844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alaproclate inhibits potassium currents and thereby enhances muscarinic stimulation in N1E-115 neuroblastoma cells.
    Hedlund B
    Neuropharmacology; 1987 Oct; 26(10):1535-40. PubMed ID: 2446190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxotremorine-induced hypothermia as a method for evaluating long-term neuronal changes following poisoning by cholinesterase inhibitors in rats.
    Grauer E; Levy A
    Toxicology; 2007 Dec; 242(1-3):1-6. PubMed ID: 17931764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.